Home » Topics » Ear, nose and throat, BioWorld Science

Ear, nose and throat, BioWorld Science
RSS

Discovery of a novel enzymatic function of histone deacetylase 11

Aug. 14, 2018

First patients dosed in phase I/II study of FX-322

Aug. 8, 2018

Otonomy initiates additional phase III trial of Otividex for Meniere's disease

July 27, 2018

New phase IIa study aims to confirm absence of anticholinergic effects with seliforant

July 25, 2018

Addition of sodium thiosulfate to cisplatin lowers incidence of cisplatin-induced hearing loss

July 24, 2018

Hearing light, no synesthesia required

July 18, 2018

KCNC1/KCNC2 channel modulators presented by Autifony Therapeutics

July 10, 2018

EMA gives positive scientific advice on development plan and regulatory pathway for AM-111

May 8, 2018

WHO grants INN seliforant to Sensorion's SENS-111

May 3, 2018

Oricula Therapeutics cleared to begin clinical testing of ORC-13661 in U.S.

Feb. 6, 2018

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...